SEDANA INSPiRE-ICU2 A Phase 3, Multicenter, Randomized, Controlled, Open-Label, Assessor-Blinded Study to Evaluate the Efficacy and Safety of Inhaled Isoflurane Delivered via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation.
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Sedana Medical AB
Start Date
March 4, 2024
End Date
February 20, 2025
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Sedana Medical AB
Start Date
March 4, 2024
End Date
February 20, 2025